基本信息
views: 259
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Current Research Interests
Dr. Panageas is involved in the analysis of cluster correlated data and random effects models in the context of health services research. She is currently involved in developing a framework for hospital profiling in cancer care in collaboration with colleagues from the Center for Health Policy and Outcomes. Profiling hospitals and/or physicians based on the quality of care they provide to patients is a priority for policy makers, payers, and the public. Her future research in this area involves evaluating risk-standardized outcomes as performance metrics after major cancer surgery across all US hospitals. The goal is to recommend a practical and technically sound statistical approach that is credible and transparent to identify providers as good or poor performers in relation to benchmarks of performance. Dr. Panageas primarily collaborates with clinical investigators from the Melanoma Service and the Departments of Neurology and Neurosurgery to design and analyze prospective and retrospective studies to evaluate treatment strategies including immuno-therapies, explore various biomarkers, develop prediction models and develop models to estimate the risk of developing distant metastasis or local tumor. She is co-Principal Investigator along with neuro-oncologist Dr. Diamond of an observational registry study of patients with Erdheim-Chester Disease (ECD) to collect baseline and follow-up clinical and patient-centered data. She also serves as the co-PI of a study to evaluate the unmet supportive care needs of patients with ECD as well as their informal caregivers. She is a member of the MSK Brain Tumor Center. She serves on the editorial board of Clin Cancer Res, JNCI and JNCI Cancer Spectrum.
Dr. Panageas is involved in the analysis of cluster correlated data and random effects models in the context of health services research. She is currently involved in developing a framework for hospital profiling in cancer care in collaboration with colleagues from the Center for Health Policy and Outcomes. Profiling hospitals and/or physicians based on the quality of care they provide to patients is a priority for policy makers, payers, and the public. Her future research in this area involves evaluating risk-standardized outcomes as performance metrics after major cancer surgery across all US hospitals. The goal is to recommend a practical and technically sound statistical approach that is credible and transparent to identify providers as good or poor performers in relation to benchmarks of performance. Dr. Panageas primarily collaborates with clinical investigators from the Melanoma Service and the Departments of Neurology and Neurosurgery to design and analyze prospective and retrospective studies to evaluate treatment strategies including immuno-therapies, explore various biomarkers, develop prediction models and develop models to estimate the risk of developing distant metastasis or local tumor. She is co-Principal Investigator along with neuro-oncologist Dr. Diamond of an observational registry study of patients with Erdheim-Chester Disease (ECD) to collect baseline and follow-up clinical and patient-centered data. She also serves as the co-PI of a study to evaluate the unmet supportive care needs of patients with ECD as well as their informal caregivers. She is a member of the MSK Brain Tumor Center. She serves on the editorial board of Clin Cancer Res, JNCI and JNCI Cancer Spectrum.
Research Interests
Papers共 529 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CANCER RESEARCH COMMUNICATIONSno. 2 (2024): 475-486
Cancer journal (Sudbury, Mass.)no. 1 (2024): 8-15
Joshua S Friedman,Benjamin H Durham, Anne S Reiner,Mariko Yabe, Kseniya Petrova-Drus,Ahmet Dogan, Melissa Pulitzer,Klaus J Busam, Jasmine H Francis,Raajit K Rampal,Gary A Ulaner,Ryan Reddy,
British journal of haematologyno. 1 (2024): 127-137
crossref(2024)
Daniel Hirschhorn,Lukas Kraehenbuehl,Sadna Budhu, Valeria Estrada Navarro,Levi Mark B Mangarin, Yacine Marouf,Jacob Ricca,Billel Gasmi,Olivier De Henau,Yanyun Li,Czrina Cortez,Hamadene Linda,
Cancer Researchno. 6_Supplement (2024): 4052-4052
Sophia McKinley,Hannah L. Kalvin, Mackenzie Shindorf,Kristen E. Rhodin,Murtuza Saifuddin,Christine Tran, Gabrielle Schwartzman,Cimarron Sharon,Aleigha Lawless,Giorgos Karakousis,Elizabeth Gaughan,Craig Slingluff,
Cited0Views0Bibtex
0
0
Cancer Researchno. 5_Supplement_1 (2024)
Erin M Bange, Robert M Daly,Allison Lipitz-Snyderman,Gilad Kuperman,Fernanda C G Polubriaginof, Chris Liebertz,Sahil D Doshi, Kristina Stevanovic, Kiana Chan,Camila Bernal, Yasin Khadem Charvadeh, Yuan Chen,
Journal of the National Cancer Institute. Monographsno. 64 (2024): 76-82
Gastroenterologyno. 5 (2024): S-577-S-578
Clinical cancer research : an official journal of the American Association for Cancer Researchno. 1 (2024): 106-115
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn